Semaglutide News

Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry - Reuters

Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry Reuters

Semaglutide fuels rapid growth in US GLP-1RA use as payments rise - News-Medical

Semaglutide fuels rapid growth in US GLP-1RA use as payments rise News-Medical

Semaglutide Tied to Lower Risk for Adult-Onset Seizure - Medscape

Semaglutide Tied to Lower Risk for Adult-Onset Seizure Medscape

Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies - Business Insider Africa

Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies Business Insider Africa

New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages - Drug Topics

New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages Drug Topics

Novo Nordisk to launch lower-cost Ozempic copy in South Africa - ETPharma.com

Novo Nordisk to launch lower-cost Ozempic copy in South Africa ETPharma.com

Why Canadians can now get cheaper generic Ozempic - and Americans can't - BBC

Why Canadians can now get cheaper generic Ozempic - and Americans can't BBC

New weight loss pill beats oral Ozempic in major trial - ScienceDaily

New weight loss pill beats oral Ozempic in major trial ScienceDaily

ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes - Fierce Pharma

ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes Fierce Pharma

One Weight Loss Strategy Is 5x More Effective Than Ozempic, Study Shows - ScienceAlert

One Weight Loss Strategy Is 5x More Effective Than Ozempic, Study Shows ScienceAlert

Semaglutide and tirzepatide extend GLP-1 benefits to liver health, mobility & longevity - Nutrition Insight

Semaglutide and tirzepatide extend GLP-1 benefits to liver health, mobility & longevity Nutrition Insight

Compounded GLP-1s: Why doctors worry and the FDA is cracking down - Stanford Medicine

Compounded GLP-1s: Why doctors worry and the FDA is cracking down Stanford Medicine

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients - Contemporary OB/GYN

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients Contemporary OB/GYN

Tirzepatide vs. Semaglutide: What You Should Know - Cleveland Clinic Health Essentials

Tirzepatide vs. Semaglutide: What You Should Know Cleveland Clinic Health Essentials

Troubling Findings in Study of GLP-1 Compounders - MedPage Today

Troubling Findings in Study of GLP-1 Compounders MedPage Today

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies - The American Journal of Managed Care® (AJMC®)

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies The American Journal of Managed Care® (AJMC®)

Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference - News-Medical

Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference News-Medical

Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes - Medical Xpress

Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes Medical Xpress

Semaglutide vs. Tirzepatide vs. Orforglipron for Weight Loss - US News Health

Semaglutide vs. Tirzepatide vs. Orforglipron for Weight Loss US News Health

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging - ScienceDaily

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging ScienceDaily

Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss - Nature

Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss Nature

Semaglutide Linked to Rare Brain Illness - Medscape

Semaglutide Linked to Rare Brain Illness Medscape

India's Dr Reddy's says semaglutide shipping disruption to last until at least late October - Reuters

India's Dr Reddy's says semaglutide shipping disruption to last until at least late October Reuters

Semaglutide dose may matter more than weight loss for heart health - News-Medical

Semaglutide dose may matter more than weight loss for heart health News-Medical

Novo Nordisk wins EU approval for Wegovy weight-loss pill - Reuters

Novo Nordisk wins EU approval for Wegovy weight-loss pill Reuters

India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters

India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial - Nature

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Nature